Entity
  • Gubra

    Created in 2008
  • BETA

    Up & running (A)
    Existing signals show a regular activity
  • Social networks

    181 17,496
  • Activities

  • Technologies

  • Entity types

  • Location

    Hørsholm Kongevej 11B, 2970 Hørsholm, Denmark

    Hørsholm

    Denmark

  • Employees

    Scale: 201-500

    Estimated: 265

  • Engaged corporates

    3
    0 3
  • Added in Motherbase

    1 year, 11 months ago
Description
  • Value proposition

    Science of certainty

    Founded in 2008, we are a biotech company with two primary areas of business: Preclinical contract research organization (CRO) services and proprietary early target and drug discovery programs.

    Our focus is the metabolic space (e.g. obesity, diabetes, NASH and gastrointestinal diseases), where we specialize in peptide chemistry, in vivo pharmacology, ex vivo assays, molecular pharmacology, histology, imaging, stereology, NGS (next generation sequencing) and bioinformatics.

    Gubra is an abbreviation for GUt and BRAin, the original key focus areas of our research and expertise.

    We work with some of the most interesting and loyal partners and customers from across the world in the pharmaceutical and biotech industry as well as academia. Through a constant focus on high quality, scientific excellence, speed and solid teamwork, we have established ourselves as a highly professional and competent partner in the market.

    in vivo pharmacology, histology, stereology, diabetes, obesity, NASH, Gastrointestinal diseases, peptide chemistry, molecular pharmacology, next generation sequencing, bioinformatics, ex vivo assays, and Imaging

  • Gubra | The Science of Certainty

    Gubra is specialized in high-end preclinical contract research and peptide-based drug discovery within metabolic and fibrotic diseases.

  • https://www.gubra.dk/
Corporate interactions BETA
Corporate TypeTweets Articles
 EU Green Capital
EU Green Capital
European Union, Environmental Services
EU Green Capital
European Union, Environmental Services
Other

24 Nov 2024


Nasdaq
Nasdaq
Finance, Financial Services
Nasdaq
Finance, Financial Services
Other

24 Nov 2024


Boehringer Ingelheim
Boehringer Ingelheim
Pharmaceutical, Pharmaceutical Manufacturing, Animal Health
Boehringer Ingelheim
Pharmaceutical, Pharmaceutical Manufacturing, Animal Health
Other

2 Jul 2024


Similar entities
Loading...
Loading...
Social network dynamics